Likewise, Kamdar and colleagues [125] found that low TET2 expression is associated with PCa metastasis and poor OS and demonstrated that the expression status of genes mediated by TET2‐mediated promoter methylation significantly associates with recurrence‐free survival in these patients (n = 423). Here, TET2 is linked to posterior cortical atrophy.